InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Martin Samuel Bates, Chief Financial Officer. Officer active across 1 company, notably Celldex Therapeutics, Inc.. Aggregated, 8 filings have been logged. Activity tracked since 10 August 2021. The latest transaction was disclosed on 2 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Martin Samuel Bates is Directeur Financier at Celldex Therapeutics, Inc. (SVP AND CFO). The 8 filings on record run from 2021-08-12 to 2026-01-06, and the sampled recent filings indicate a transaction nature mainly related to option exercise, with amounts of EUR 239492.5447782532, 79233.4429162756, 42551.89240624182, 27072.8223749297, 26876.12642516499, and 25866.3144239374.